Rheumatoid arthritis: Biologics in second-line therapy show benefit
The German Institute for Quality and Efficiency in Health Care (IQWiG) examined 9 biotechnologically produced drugs for the treatment of adults with rheumatoid arthritis in whom prior pharmacological treatment had failed. ...
Aug 30, 2013